Background
==========

Cough is the most common complaint leading patients to consult with primary care physicians \[[@B1],[@B2]\]. Cough is a vital protective mechanism for clearing foreign material or excessive secretions from the airways. The common cold is the most frequent cause of cough in the acute (*i.e.*, \<3 weeks in duration) setting and is usually self-limiting. However, a persistently troublesome chronic cough (*i.e.*, \>8 weeks in duration) of obscure aetiology has been shown to be one of the most common reasons for new patient visits to respiratory physicians in secondary/tertiary care \[[@B3]\].

Gastro-oesophageal reflux is a common cause of chronic cough \[[@B4]\]. A number of studies have reported a higher incidence of classic acid related reflux symptoms (gastro-oesophageal reflux disease (GORD)) in overweight and obese people \[[@B5]-[@B8]\]. In a systematic review of 16 studies of GORD management, weight loss was associated with improved oesophageal pH profiles and GORD related symptoms \[[@B9]\]. We have recently demonstrated an association of a chronic cough with obesity \[[@B10]\] and have observed in clinical practice that weight gain can be associated with the onset of chronic cough. The effect of weight loss on cough has not been studied.

The traditional dietary advice given to GORD patients is not concerned with weight loss, but is centred around dietary modifications, for example avoidance of spicy foods, coffee, alcohol and high fat foods \[[@B11],[@B12]\]. However recent studies have been unable to confirm the efficacy of such measures \[[@B9],[@B13],[@B14]\]. A systematic review concluded that there was insufficient data to support or refute common recommendations to change diet \[[@B15]\]. Thus the evidence base for such advice appears poor and the prevailing opinion is summarised by DeVault and Castell who suggest that traditional diet therapy 'may benefit many patients with GORD, although these changes alone are unlikely to control symptoms in the majority of patients' \[[@B16]\]. The current National Institute of Clinical Excellence (NICE) guidance is more dismissive "available trials of lifestyle advice to reduce symptoms of dyspepsia are small and inconclusive" and that there is "no clear association between dyspepsia and other lifestyle factors: smoking, alcohol, coffee, and diet" \[[@B17]\]. Thus there is a conflict between traditional dietary practice and the evidence for the role of conventional dietary intervention in GORD.

The form of reflux leading to cough is different in constitution, location and timing to that associated with classic GORD symptoms such as heartburn \[[@B18]\]. These reflux events may be extra-oesophageal, of a shorter duration and not necessarily acid in nature. The diagnosis of such airway reflux relies on the clinical history, but may be established by the use of validated, reproducible and responsive questionnaires such as the Hull Airways Reflux Questionnaire (HARQ) \[[@B19]\]. The differences between airway reflux and classic GORD symptoms has previously lead to diagnostic confusion with many patients being mislabelled as suffering from an asthmatic or idiopathic cough.

We hypothesised that weight reduction may be a useful non-pharmacological strategy for patients presenting with chronic cough. We therefore undertook a study comparing two dietetic strategies, weight loss and anti-reflux, in obese patients with a positive HARQ response indicating significant symptoms of airway reflux. As a weight loss strategy we used the energy prescription method (EP) as described by Frost et al. \[[@B20]\]. This was compared with the traditional GORD anti-reflux diet suggested within the Manual of Dietetic Practice \[[@B21]\] in an open parallel group study.

Brief statement of findings
---------------------------

We assessed two different dietary regimens and whether they would help attenuate cough reflux. We found that weight reduction, irrespective of diet reduced cough reflux symptoms and this has not been found before.

Methods
=======

Patients were recruited from the Hull Cough Clinic at Castle Hill Hospital. The study was approved by the local research ethics committee (South Humber Local Research Ethics Committee; REC04/Q1105/62). The study was registered with the Research and Development Department, Clinical Governance Directorate, Hull and East Yorkshire Hospitals NHS Trust (reference number R0086). The study was completed between June 2005 and September 2009.

Patients
--------

Patients were diagnosed as have cough secondary to airway reflux based on the validated HARQ score of \>13 \[[@B19]\]. This is represents the upper limit of normal on the self-completed, fourteen component instrument. Based on the WHO classification of obesity \[[@B22]\], patients with a body mass index (BMI) \>25 kg/m^2^ were asked whether they wished to participate in a trial of dietary intervention. Following informed consent patients were randomised in a double-blinded manner using a Latin Square fashion to one of two open parallel groups.

Intervention
------------

One group received the traditional dietary modifications consisting of personalised advice concerning eating smaller meals at regular intervals; avoiding eating late at night; avoiding bending/lifting or lying down after meals, and general encouragement to lose weight by following a balanced diet plan \[[@B23]\]. Excessive consumption of tea/coffee/alcohol was to be avoided as was highly spiced or irritant foods or particular foods known to exacerbate symptoms. Sleeping in a semi-upright position or raising the head of the bed to help prevent nocturnal symptoms of reflux was encouraged \[[@B21]\].

The other group received dietary advice on weight reduction in the form of an EP diet \[[@B20]\]. The EP is calculated using the individual's basal metabolic rate (BMR) based on age, gender and weight in kg, adding on a physical activity level (PAL) based on gender and activity level to then calculate estimated energy requirements (EER). The EER then has 600 kcal subtracted. An individualised balanced menu plan is then provided with guidance on portion sizes.

At baseline all patients had dietary and anthropometric assessments and were advised on the dietary treatment plan by a registered dietician (JS). Both groups were asked to complete the Leicester Cough Questionnaire \[[@B24]\] and 5 day food diaries at the beginning and end of the 6 month observation study period. All patients were reviewed at monthly intervals when compliance was assessed and dietary advice reinforced.

Analyses
--------

Baseline and demographic data were expressed as mean (± standard deviation (SD)) or median (interquartile range). Post-intervention data were also similarly expressed. Statistical comparisons of the effect of the interventions within and between groups were carried out using Wilcoxon-signed rank and Kruskal-Wallis test respectively. Due to the high drop out rate and inequality between the two groups modified intention to treat (ITT) analyses was performed. Missing observations were imputed using last outcome carried forward, though we note this approach is not without its limitations \[[@B25]\]. A two-tailed p value of less than 0.05 was considered to indicate statistical significance. All analyses were performed with the Statistical Package for Social Science (SPSS for windows version 18.0, Chicago, IL, USA). Correlation assessments were conducted and were expressed as R and p values. Food diary analysis was completed using the Microdiet© Plus for Windows (version 1.2, 2001)*.*

Results
=======

The flow diagram in Figure [1](#F1){ref-type="fig"} demonstrates the progress through the phases of the open parallel randomised trial for both groups. Thirty three patients (26 female) consented to take part in the study, mean age 56.7 years. Twenty subjects (16 female) with a mean age 58.6 years completed the study. At baseline they had a mean HARQ score of 30/70. Baseline parameters of the patients are depicted in Table [1](#T1){ref-type="table"} and the change in parameters from baseline are depicted in Table [2](#T2){ref-type="table"}.

![Flow diagram of the progress through the phases of the study.](1745-9974-9-27-1){#F1}

###### 

Baseline parameters of all consented, energy prescription and reflux diet patients in the study

  **Parameter**            **Consented patients (N = 33)**   **Energy prescription Gp patients (N = 18)**   **Reflux diet Gp patients (N = 15)**
  ------------------------ --------------------------------- ---------------------------------------------- --------------------------------------
  Age\*                    58.6 (±13.4)                      58.0 (±14)                                     59.0 (±13)
  Sex                      4 M/16 F                          3 M/10 F                                       1 M/6 F
  Baseline weight (Kg)\*   89.0 (±17.4)                      89.9 (±13.7)                                   87.5 (±24.0)
  Baseline BMI (kg/m2)\^   34.0 (29.8, 35.3)                 33.6 (30.5, 34.9)                              31.8 (28.5, 35.6)
  Baseline LCQ score\*     14.4 (±3.8)                       6.8 (±2.6)                                     2.58 (±1.61)
  Baseline Kcal\^          1266.7 (1138.5, 1532.9)           1396.7 (1147.9, 1615.9)                        1165.9 (1138.5, 1336.9)
  Baseline fat\^           41.8 (32.8, 57.1)                 51.2 (31.6, 64.4)                              41.4 (35.6, 65.6)

\*Expressed as mean (± standard deviation).

\^Expressed as median (interquartile range).

*Abbreviations:Gp* Group, *N* number, *M* male, *F* female, *Kg* kilograms, *BMI* body mass index, *kg/m2* kilogram per metres squared, *LCQ* Leicester cough questionnaire, *Kcal* Kilocalories.

###### 

Change in parameters for the intention to treat cohorts for the energy prescription and reflux diets

  **Parameter**            **Energy prescription diet**                             **Reflux diet**            
  ------------------------ ------------------------------ ------------------------- ------------------------- -------------------------
  Baseline weight (Kg)\*   89.9 (±13.7)                   85.9 (±15.4)              87.5 (±24.0)              82.1 (±24.0)
  Baseline BMI (kg/m2)\^   33.6 (30.5, 34.9)              32.5 (28.3, 34.3)         31.8 (28.5, 35.6)         29.7 (26.1, 34.4)
  Baseline LCQ score\*     6.8 (±2.6)                     6.2 (±2.5)                2.58 (±1.61)              13.5 (±3.7)
  Baseline Kcal\^          1396.7 (1147.9, 1615.9)        1493.4 (1147.9, 1615.9)   1165.9 (1138.5, 1336.9)   1400.4 (1276.9, 1552.0)
  Baseline fat\^           51.2 (31.6, 64.4)              53.7 (48.6, 64.4)         41.4 (35.6, 65.6)         48.7 (47, 71.2)

\*Expressed as mean (± standard deviation).

\^Expressed as median (interquartile range).

*Abbreviations:Gp* Group, *N* number, *M* male, F female, *Kg* kilograms, *BMI* body mass index, *kg/m2* kilogram per metres squared, *LCQ* Leicester cough questionnaire, *Kcal* Kilocalories.

Mean weight loss was 3.1 kg representing a 0.4% (range -3 -- 11%) weight loss of all patients (p \< 0.001). All but two completing patients lost weight. Mean weight loss in patients completing the programme was 3.9%. In both intervention arms there was a similar and significant weight loss. For the EP group mean reduction was 3.2 kg (p = 0.001), and for the anti-reflux diet group a mean reduction of 2.63 kg (p = 0.012).

At baseline, mean BMI 34 kg/m^2^ (range 26-50.8 kg/m^2^). There were similar and significant changes from baseline to end of study for the EP group (mean reduction 1.3 kg/m^2^ (p = 0.001)), and for the anti-reflux diet group (mean reduction 1.2 kg/m^2^ (p = 0.011)) (Table [1](#T1){ref-type="table"}; Figures [2](#F2){ref-type="fig"}a, [2](#F2){ref-type="fig"}b).

![**Change in weight and BMI from baseline to end of study. (a)** weight (kg). **(b)** BMI (kg/m2).](1745-9974-9-27-2){#F2}

Sixteen patients submitted food diaries at both the start and end of the trial. 10 of these subjects were in the EP group. Surprisingly for both groups the food diary analysis from baseline to end of study, showed an increase in both calorie and fat intakes, though these increases were not significant. For the EP group the mean increase in calories consumed was 96.7 kcal (p = 0.4) and for the anti-reflux diet group was 234.5 kcal (p = 1.0). The mean increase in fat intake for the EP group was 2.5 g (p = 0.8) and for the anti-reflux diet group was 7.3 g (p = 0.8) (Table [2](#T2){ref-type="table"}).

The mean change in LCQ score was 3.1 units in all the consented patients. There was an increase (improvement in LCQ) was similar (3.6 units for the EP group and 2.5 units for the anti-reflux diet group) (Table [2](#T2){ref-type="table"}). All of the patients who completed the study achieved an improvement in their cough score (range 2.5 to 7.7) above the minimal clinically significant (MCS) score of 1.3 \[[@B26]\]. Secondary correlation analysis of the baseline data from the food diary showed that high calorie and fat intakes were significantly associated with a worse quality of life score (calories (r = -0.24; P \< 0.001); fat (r = -0.36; P = 0.001)) (Figure [3](#F3){ref-type="fig"}a, [3](#F3){ref-type="fig"}b).

![**Correlations of calorie and fat intakes with LCQ score at baseline, (a)** calorie (kcal). **(b)** fat (g).](1745-9974-9-27-3){#F3}

Discussion
==========

Chronic cough associated with gastro oesophageal reflux is a common but frequently under diagnosed condition. This is due to the 'atypical' presentation with symptoms of non-peptic, extra-oesophageal origin. To define this syndrome a variety of questionnaires such as the Reflux Symptom Index have been developed. In this study we have used the HARQ, a questionnaire developed specifically to quantify the symptoms of airway reflux underlying cough hypersensitivity. Our patients all exhibited HARQ scores above the cut off of 13/70 required to diagnose airway reflux and represent a distinctive population of patients with reflux induced cough hypersensitivity syndrome \[[@B19]\].

There is a dearth of treatment options available to patients with airway reflux. Pharmacotherapy with conventional acid suppression has recently been shown to be no more effective than placebo \[[@B27]\] presumably because of the non-peptic nature of the tussive stimulus. Pro-motility agents such as metoclopramide, domperidone and macrolides have been advocated, but there is a lack of randomised control trials supporting their use. The only evidence based therapy is oral opiates \[[@B28]\], which do not treat reflux but suppresses cough reflex hypersensitivity centrally.

Non-pharmacological treatment has been shown to be effective. Specific cough related speech therapy has been demonstrated to diminish cough reflex sensitivity and improve quality of life \[[@B29]\]. We had previously observed a significant relationship between obesity and chronic cough in a survey of the general population \[[@B10]\]. This observation is mirrored in studies showing an increase of obesity related GORD \[[@B30]\]. This led us to hypothesize that weight reduction may offer a further non-pharmacological treatment option in obese chronic cough patients.

We have tested this hypothesis by comparing two dietary measures that may aid resolution of airway reflux. The traditional 'textbook' GORD anti-reflux diet was compared to an EP diet, targeting weight control. We showed no difference between these two strategies, both of which produced weight loss and a reduction in cough score. Surprisingly, percentage weight loss was slightly greater in the traditional 'textbook' GORD anti-reflux diet group, and there appears to be little evidence that dietary intervention needs to follow a restriction of foods of any particular 'refluxogenic' type for improvement to be manifest.

Analyses of the food diaries at baseline showed current high intakes of calories and fat had an adverse effect on cough quality of life suggesting that this may contribute to chronic cough. Other studies in GORD have demonstrated an association of a high fat intake and the occurrence of reflux \[[@B11],[@B12]\]. Moreover, weight loss has been shown to improve pH profiles and symptoms in GORD patients \[[@B9]\]. An alternative mechanism to explain our observation may be that the high fat and calorie intake leads to weight gain which in turn causes reflux. This is supported by research suggesting that reflux is more prevalent in the overweight and obese population rather than the lean \[[@B5]-[@B8]\].

Since there was no non-intervention group in our study it is impossible to say whether the dietary measures directly contributed to the improvement in cough quality of life. Chronic cough may follow a waxing and waning course \[[@B31]\] and it is possible that the improvement in cough score may be explicable by regression to the mean from the pre study baseline. The effectiveness of a dietary intervention on cough however, with all of the patients who completed the study showing a greater than MCS improvement in cough quality of life score, would tend to suggest a clinically important effect of this intervention.

In interpreting our observations one needs to take into account some limitations in our study. Firstly, recruitment to the study was slower than expected due to 21 patients who declined to take part from the outset despite encouragement from the medical team. Patients in the Hull Cough Clinic often request advice on lifestyle modification and it was perhaps surprising that these proposals were rejected when offered. There are many factors that contribute to a person's motivation to lose weight which include their readiness for change and barriers to change such as how diet and exercise affects health. As our study required that the patient to be reviewed monthly over a seven month period, study duration may have been a contributing factor. An individual's perceived lack of time is one of the barriers to change \[[@B32]\]. NICE Guidelines on Obesity however, recommends that 'regular, non-discriminatory long term follow up by a trained professional should be offered' \[[@B32]\]. It is possible that these recommendations may hamper rather than aid compliance. Secondly, as with many studies into the effect of lifestyle change, this study could not use a blinded methodology. As a consequence all patients recruited were aware of our hypothesis that weight loss would contribute to a reduction in reflux cough. Thirteen of the recruited subjects dropped out of the study, with 8 subjects providing no reason. A number who completed the study stated that they were disappointed to be allocated into what was perceived as the control group, i.e. the traditional anti-reflux diet. Moreover, the overall number of patients who completed the study was small. Thirdly, we did not perform objective assessments of GORD since existing techniques are poorly correlated with non acid reflux as determined by symptom assessment. There is an urgent need for such measurements to be developed. Additionally we did not study objective parameters of cough and we acknowledge this as a weakness of the study. The above may have diminished our understanding of the pathobiological basis of the cough reduction seen. In particular, Obstructive Sleep Apnoea (OSA) in obese subjects can rarely precipitate cough \[[@B33]\], and maybe improved by weight reduction. While we have shown statistical significance effects however, studies on larger numbers of patients will be required to draw definitive conclusions.

Conclusion
==========

In this study we report for the first time if weight loss is achieved irrespective of diet there is a reduction on cough quality of life symptoms. Furthermore, we have shown a strong correlation between a high calorie and fat intake with LCQ score. Simply asking subjects to lose weight by reducing fat and calorie intake may be a useful strategy for the management of intractable cough in primary care.
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